• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病完全和不完全患儿冠状动脉损伤风险及中介机制。

Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease.

机构信息

Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, China.

Institute of Cardiovascular Development and Translation Medicine, Wenzhou Medical University, Wenzhou, China.

出版信息

J Investig Med. 2019 Aug;67(6):950-956. doi: 10.1136/jim-2018-000898. Epub 2019 Feb 25.

DOI:10.1136/jim-2018-000898
PMID:30804174
Abstract

To compare the risk of coronary artery lesions (CAL) in children with complete and incomplete Kawasaki disease (KD) before and after immunoglobulin therapy and explore the mediation mechanisms underlying this association. All patients with KD admitted to the Wenzhou Medical University affiliated Yuying Children's Hospital were divided into complete and incomplete KD groups. The independent effect of KD type on the risk of CAL and the intermediate effect of admission time on the association between KD type and CAL were assessed. The incidence of CAL in children with incomplete KD was higher than that in children with complete KD (33.9% vs 23.0%, p<0.001), and was also higher before therapy (27.5% vs 14.8%). Among children without CAL before therapy, there was no statistical difference in the incidence of CAL after treatment between the two groups. Mediation analysis found that the mediating effect of admission time was 1.07 (95% C: 1.01 to 1.13), and the direct effect of KD type on CAL was 1.59 (95% CI 1.17 to 2.16); proportion mediated was 15.71%. In conclusion, the risk of CAL among patients with incomplete KD was higher than that for complete KD, especially before therapy. In patients without CAL before treatment, the risk of CAL after treatment was equivalent for the two groups. Delayed admission may be one of the important mediating mechanisms for the higher risk of CAL in incomplete KD children.

摘要

目的

比较完全型和不完全型川崎病(KD)患儿免疫球蛋白治疗前后冠状动脉病变(CAL)的风险,并探讨其关联的中介机制。

方法

将温州医科大学附属育英儿童医院收治的所有 KD 患儿分为完全型和不完全型 KD 组。评估 KD 类型对 CAL 风险的独立影响以及入院时间对 KD 类型与 CAL 之间关联的中介效应。

结果

不完全型 KD 患儿的 CAL 发生率高于完全型 KD 患儿(33.9%比 23.0%,p<0.001),且治疗前更高(27.5%比 14.8%)。在治疗前无 CAL 的患儿中,两组治疗后 CAL 的发生率无统计学差异。中介分析发现,入院时间的中介效应为 1.07(95%CI:1.011.13),KD 类型对 CAL 的直接效应为 1.59(95%CI:1.172.16);中介比例为 15.71%。

结论

不完全型 KD 患儿的 CAL 风险高于完全型 KD 患儿,尤其是在治疗前。在治疗前无 CAL 的患儿中,两组治疗后 CAL 的风险相当。延迟入院可能是不完全型 KD 患儿 CAL 风险较高的一个重要中介机制。

相似文献

1
Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease.川崎病完全和不完全患儿冠状动脉损伤风险及中介机制。
J Investig Med. 2019 Aug;67(6):950-956. doi: 10.1136/jim-2018-000898. Epub 2019 Feb 25.
2
[The mediation mechanism of coronary artery lesions in both male and female patients with Kawasaki disease].[川崎病男性和女性患者冠状动脉病变的中介机制]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Dec 10;40(12):1634-1638. doi: 10.3760/cma.j.issn.0254-6450.2019.12.024.
3
Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.静脉注射免疫球蛋白治疗后中性粒细胞减少与川崎病患儿冠状动脉病变的相关性:一项病例对照研究
BMC Pediatr. 2018 Feb 21;18(1):76. doi: 10.1186/s12887-018-1032-z.
4
Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.影响川崎病患者冠状动脉病变持续时间的因素:一项回顾性队列研究。
Pediatr Rheumatol Online J. 2021 Jun 26;19(1):96. doi: 10.1186/s12969-021-00589-z.
5
[Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].血清基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1对川崎病患者冠状动脉病变的预测及早期诊断的临床价值
Zhonghua Er Ke Za Zhi. 2005 Sep;43(9):676-80.
6
Risk factors for coronary artery lesions in children with Kawasaki disease.川崎病患儿冠状动脉病变的危险因素。
Arch Argent Pediatr. 2020 Oct;118(5):327-331. doi: 10.5546/aap.2020.eng.327.
7
[Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].[5岁以上川崎病患儿冠状动脉病变的预测指标及风险模型构建]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 May 15;26(5):461-468. doi: 10.7499/j.issn.1008-8830.2309103.
8
[Risk factors for coronary artery lesions secondary to Kawasaki disease in children].[儿童川崎病继发冠状动脉病变的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Sep;17(9):927-31.
9
Right ventricular-pulmonary artery coupling is an independent risk factor for coronary artery lesions in children with Kawasaki disease.右心室-肺动脉耦联是川崎病患儿冠状动脉病变的独立危险因素。
Coron Artery Dis. 2024 Jun 1;35(4):328-332. doi: 10.1097/MCA.0000000000001335. Epub 2024 Jan 22.
10
Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.川崎病临床特征及相关影响因素的回顾性分析。
Medicine (Baltimore). 2022 Dec 30;101(52):e32430. doi: 10.1097/MD.0000000000032430.

引用本文的文献

1
Incomplete Kawasaki disease presenting primarily with cough: a case report and brief literature review.主要以咳嗽为表现的不完全川崎病:一例报告及文献简要综述
BMC Pediatr. 2025 Aug 20;25(1):632. doi: 10.1186/s12887-025-05957-2.
2
A risk stratification model for coronary artery lesions in Kawasaki disease: focus on subgroup-specific utility.川崎病冠状动脉病变的风险分层模型:关注亚组特异性效用。
Front Cardiovasc Med. 2025 Apr 29;12:1543767. doi: 10.3389/fcvm.2025.1543767. eCollection 2025.
3
Clinical characteristics of cervical lymphadenopathy in Kawasaki disease and the generation of related cervical complications: a retrospective cohort study.
川崎病颈部淋巴结病的临床特征及相关颈部并发症的发生:一项回顾性队列研究
Eur J Med Res. 2025 Apr 16;30(1):295. doi: 10.1186/s40001-025-02556-w.
4
Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.中国儿童不完全川崎病诊断与治疗指南。
BMC Pediatr. 2024 Jul 26;24(1):477. doi: 10.1186/s12887-024-04961-2.
5
[Diagnosis and treatment of incomplete Kawasaki disease in children].[儿童不完全川崎病的诊断与治疗]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):238-243. doi: 10.7499/j.issn.1008-8830.2209127.
6
A case report of atypical Kawasaki disease presented with severe elevated transaminases and literature review.一份以严重升高的转氨酶为表现的非典型川崎病病例报告及文献复习。
BMC Infect Dis. 2021 May 4;21(1):415. doi: 10.1186/s12879-021-06101-y.
7
Correct identification of incomplete Kawasaki disease.不完全川崎病的正确识别。
J Int Med Res. 2021 Mar;49(3):3000605211001712. doi: 10.1177/03000605211001712.
8
Difference in serum miRNA expression between immunoglobulin-sensitive and -insensitive incomplete Kawasaki disease patients.免疫球蛋白敏感型与不敏感型不完全川崎病患者血清微小RNA表达的差异。
Exp Ther Med. 2021 Feb;21(2):162. doi: 10.3892/etm.2020.9593. Epub 2020 Dec 18.
9
Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study.区分川崎病与发热性感染的血清生物标志物:一项初步病例对照研究。
Saudi J Biol Sci. 2020 Dec;27(12):3428-3433. doi: 10.1016/j.sjbs.2020.09.034. Epub 2020 Sep 23.
10
Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease.川崎病患儿免疫球蛋白治疗前冠状动脉病变的预后和危险因素。
Balkan Med J. 2020 Oct 23;37(6):324-329. doi: 10.4274/balkanmedj.galenos.2020.2020.1.56. Epub 2020 Jul 28.